Cervical Cancer

Advancing women’s health: optimising cervical cancer screening in Thailand

Advancing women’s health: optimising cervical cancer screening in Thailand

Since 2020, Thailand has used HPV DNA tests as a way to optimise primary screening programmes for cervical cancer. The country conducted internal studies on the cost-effectiveness of HPV tests within primary screening and found it economical. To increase coverage amongst the unscreened or under-screened population, self-sampling was introduced to address cultural and/or religious barriers […]

Advancing women’s health: optimising cervical cancer screening in Thailand Read More »

Advancing women’s health: HPV screening methods in Singapore

Advancing women’s health: HPV screening methods in Singapore

HPV screening programmes are being rolled out across many countries in a bid to eliminate cervical cancer by 2030, a target that has been set out by the World Health Organisation. As more countries gain access to innovative technology and greater experience in cervical cancer screening, some are exploring updating screening algorithms in order to

Advancing women’s health: HPV screening methods in Singapore Read More »

Advancing women’s health: key takeaways from AOGIN 2022

Advancing women’s health: key takeaways from AOGIN 2022

With face-to-face conferences and scientific symposiums back on, the Lab Insights team recently attended the 14th meeting of the Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN 2022). Distinguished speakers from around the world gathered to talk about human papillomavirus (HPV) and the several cancers it can cause, the most notable among them being

Advancing women’s health: key takeaways from AOGIN 2022 Read More »

Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong

Advancing Women’s Health: Project Teal drives cervical cancer screening in Hong Kong

  To find out more about the Karen Leung Foundation and the work they do, please click here. In Hong Kong, cervical cancer ranked as the 8th most common cancer and cause of mortality amongst women in 2019 [1]. Despite a national screening programme implemented in 2004, studies show that close to 40% of women

Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong Read More »

APEC policy dialogue on cervical cancer management highlights role of clinical labs

APEC policy dialogue on cervical cancer management highlights role of clinical labs

This article is part of a series on diagnostics within Women’s Health. We’ll be adding more stories and related content throughout the year. Check out the first story in this series about cervical cancer triage testing here.  On Jan 28, cervical cancer experts from across the Asia Pacific region and around the world came together

APEC policy dialogue on cervical cancer management highlights role of clinical labs Read More »

Advancing women’s health: p16/Ki-67 dual staining technology improves cervical cancer diagnostics

Advancing women’s health: p16/Ki-67 dual staining technology improves cervical cancer diagnostics

To learn more about how cervical cancer impacts the lives of women globally and the steps organisations are taking to eliminate this disease globally, please visit the Conquering Cancer campaign. Click here for videos related to the campaign.  This article is part of a new series on diagnostics within Women’s Health. We’ll be adding more

Advancing women’s health: p16/Ki-67 dual staining technology improves cervical cancer diagnostics Read More »

HPV screening and vaccination in Asia: overcoming barriers to access

HPV screening and vaccination in Asia: overcoming barriers to access

Cervical cancer is the 4th leading type of cancer amongst women in the world. Caused by human papillomavirus (HPV) infection, cervical cancer is highly preventable through the use of prophylactic measures like HPV vaccines and robust screening programmes. Through the launch of the Global Strategy to Accelerate the Elimination of Cervical Cancer in late 2020,

HPV screening and vaccination in Asia: overcoming barriers to access Read More »

Time to review the gold standard for cervical cancer screening

Time_to_review

More than 5,000 women in Thailand die every year from cervical cancer [1], according to the 2019 report from the HPV Information Centre. 70% of these cancers are caused by just two human papillomavirus (HPV) strains: HPV16 and HPV18. Both of these strains are now vaccine-preventable, but the HPV Information Centre estimates that it will take decades

Time to review the gold standard for cervical cancer screening Read More »

Scroll to Top